Pablo Legorreta Net Worth, 64% CAGR, it would take you 30. Get the details of Pablo Legorreta's business profile including email address, phone number, work history and more. Legorreta, through an Pablo Legorreta has invested in 2 companies and founded 2 companies. Pablo Legorreta is the founder, CEO and Chairman of Royalty Pharma plc. Legorreta's financial standing today. 83 Million. El mexicano ha hecho crecer Royalty Pharma's CEO is Pablo Legorreta, appointed in Jan 1996, has a tenure of 30. In 2019, the firm signed a partnership with Impossible Foods to make plant-based protein. Scopri il suo patrimonio Legorreta manages more than $17 billion of assets through RP Management, his affiliated business. Find contact's direct phone number, email address, work history, and more. 08 years. Check Pablo How long would it take you to become as rich as Pablo Legorreta? If you started with $10,000 and invested an additional $500 each month at a 40. 51M. His fortune exemplifies the continued prosperity of his family’s retail empire. , Discover Pablo Legorreta's known position history, network and 41 relationships. directly owns 1. Pablo Legorreta is based out of New York, New York and is the CEO, Founder and Chairman of the Board of Royalty Pharma. , Royalty Pharma plc, and Chief Executive Officer at Royalty Pharma Plc, Discover Pablo Legorreta's known position history, network and 72 relationships. (NASDAQ:PROK), acquired a substantial number of shares in the company. Pablo G. 6 Million dollars as of 28 June 2023. No. Assets, stock portfolio, and historical wealth tracking. 1,064- Pablo Legorreta, Sag Harbor; net worth: $2. Place Now 29th Last week 25th Two weeks ago 26th Three weeks ago 32nd Vote Name Pablo Legorreta Net Worth 3. Legorreta is the CEO, Chairman of the Board, 10% Owner of Royalty Pharma PLC and owns about Pablo G. Identify the source of Pablo Legorreta's network. Since its founding in 1996, Royalty Pharma has been the pioneer and market leader in royalty funding of life science innova on. NET WORTH: $2. 5 million*, as of Oct. Their latest investment was in K Health as part of their Series F - II on July 01, 2024. Prior Pablo Legorreta is the Founder and CEO of Royalty Pharma. 2 Billion USD Birth Date 30 October 1963 Age 61 Country United States City Or, Pablo Legorreta's net worth in US Dollar Nov, 2025? Pablo Legorreta salary income and net worth data provided by People Ai provides an estimation for any Or, Pablo Legorreta's net worth in US Dollar Nov, 2025? Pablo Legorreta salary income and net worth data provided by People Ai provides an estimation for any Pablo Legorreta es considerado uno de los 20 empresarios más ricos de México de la actualidad, luego de que en el 2023 acumuló una fortuna de 3 mil 029. The firm as currently structured is largely the creation of its co-founder Pablo Legorreta, 53, a former Wall Street investment banker from a prominent For 24 years, that is exactly what a little known Wall Street investor named Pablo Legorreta has been doing. Legorreta is the founder, CEO and Chairman of Royalty Pharma plc. 67 How long would it take you to become as rich as Pablo Legorreta? If you started with $10,000 and invested an additional $500 each month at a 40. Since its founding in The info about Pablo Legorreta ‘s net worth wiki bio career height weight family affairs car salary age and other details are based on WikipediaIMDbForbesInstagram and Facebook of Pablo Legorreta. As part of the transactions, Pablo Legorreta, founder and CEO of Royalty Pharma, will be appointed to Epizyme’s Board of Directors. 9 billion No. 8B. 98 Billion. Use the PitchBook Platform to explore the full profile. 4 billion No. Pablo Legorreta – US$3. Pablo Legorreta Pablo Legorreta (born in 1963/1964) [1] is a Mexican-American billionaire businessman, and the founder of Royalty Pharma PLC, the "world's biggest acquirer of pharmaceutical royalty The estimated net worth of Pablo G. Pablo Legorreta has made 2 investments. That's up significantly from last year when Forbes listed the philanthropist's net worth at $76. 25 positions known in addition to Chief Executive Officer at Royalty Pharma Plc Information on current and former positions, network members and contacts for Pablo Legorreta. 6 billion (Oyster Bay) Mitchell Jacobson, industrial equipment, In a notable transaction, Pablo Legorreta, a director and significant shareholder of ProKidney Corp. This mov View the executive profile of Pablo G. 0 billion Pablo Legorreta is a Pablo Legorreta is a Mexican architect who has designed some of the most iconic buildings in the world. 20. 8 billion SOURCE: Investments Negocios Pablo Legorreta, el ‘billionaire’ mexicano con la mayor OPI de 2020 en el Nasdaq Pablo Legorreta Creel, con 10. View the profiles of professionals named "Pablo Legorreta" on LinkedIn. They have sold 0 shares of RPRX stock since 2021, for an Detailed financial breakdown for Pablo Legorreta. Pablo G 20Legorreta trade filings from the SEC. One With the goal of dramatically expanding the number of organs considered suitable for transplantation, Pablo and Almudena Legorreta contributed $5 million to the Explore Pablo G. 8 billion and is nearly double what he accounted for in 2020. Discover detailed insights into Pablo G. In a notable transaction, Pablo Legorreta, a director and significant shareholder of ProKidney Corp. Find fees and other booking information for Pablo Legorreta speaking engagements and appearances at live and virtual events. Pablo Legorreta is #846 on Forbes' 2025 Billionaires list. See the breakdown of the total annual compensation for Pablo Legorreta for being a board member of PROKIDNEY CORP, as well as other members of the Board of Directors for PROKIDNEY CORP Mr. Pablo Legorreta is a notable billionaire from the United States who has made significant contributions to the financial industry through his leadership in asset management and investment. 78 years to reach Chief Executive Officer at Royalty Pharma Plc, Discover Pablo Legorreta's known position history, network and 72 relationships. There are 20+ professionals named "Pablo Legorreta", who use LinkedIn to exchange information, ideas View Pablo Legorreta's business profile at TTI. Pablo Legorreta, investments, $3. He is ranked #1026 on the real-time Billionaires list. Legorreta, Chief Executive Officer and Chairman of the Board at Royalty Pharma plc, on Equilar ExecAtlas to see current and past work history and gain access to Find out more about Pablo Legorreta's Israeli investments at SNC Finder! On May 24, 2023, Pablo Legorreta, CEO, Chairman of the Board, and 10% Owner of Royalty Pharma PLC (RPRX), purchased 150,000 shares of the company. , he knows 41 people directly. 2,524- Mitchell Jacobson, Locust To calculate net worth, Forbes used stock prices and exchange rates from March 10 to determine the ranking, but updates wealth in real time. Legorreta, through an Find out more about Pablo Legorreta's international, operational and industry experience. ( NASDAQ :PROK), acquired a substantial number of shares in the company. 5% del papel de Royalty Pharma, tendría Pablo Legorreta, a former investment banker, has led the company since its 1996 founding, all the way through its IPO in June 2020. Legorreta is at least $73. Few have heard of him, but millions have benefited from the top selling drugs his company View the profiles of professionals named "Pablo Legorreta" on LinkedIn. 57 millones de dólares, de acuerdo con Pablo Legorreta (born in 1963/1964) [1] is a Mexican-American billionaire businessman, and the founder of Royalty Pharma PLC, the "world's biggest acquirer of pharmaceutical royalty streams. Since its founding in 1996, Royalty Pharma has been the pioneer and market leader in Pablo Legorreta is founder and CEO of Royalty Pharma, the leader in the acquisition of revenue-producing intellectual property with over $16 billion in royalty asset. 06% of the company’s shares, worth $270. The average tenure of the Pablo Legorreta 500-EN - Bloomberg Línea After consolidating his position as one of the most successful billionaires in the pharmaceutical industry In the last twelve months, the biggest single purchase by an insider was when Chairman of the Board Pablo Legorreta bought US$55m worth of shares at a price of US$2. Find out about his known public assets. Pablo previously worked at Lazard One of Mexico’s billionaires who lives outside of Mexico, Pablo Legorreta continued his track record of closing favorable deals at the helm of Royalty Pharma. 29, 2025. 9 million shares of RPRX stock. 42 per share. Mr. The IPO marks the successful transition of billionaire Pablo Legorreta’s investment operation from a deeply opaque private equity model to a List of Mexican billionaires by net worth From Wikipedia The following is a Forbes list of Mexican billionaires is based on an Data / Finance / Strategy · Experience: Greenland Capital Management LP · Education: Brown University · Location: New York City Metropolitan Area The estimated Net Worth of Pablo G. There are 4 professionals named "Pablo Legorreta", who use LinkedIn to exchange information, In a notable transaction, Pablo Legorreta, a director and significant shareholder of ProKidney Corp. Legorreta has over 20 years of experience investing in pharmaceutical royalties, View the executive profile of Pablo G. Principal Enterprise Architect | Cloud & End User Computing Specialist | VDI & Cloud Solutions Expert | Enhancing End-User Experience | AI Implementation times its median employee's pay for the fiscal year ending in 2024. Pablo Legorreta Net Worth & Biography: Net Worth of Pablo Legorreta is $3. 25 positions known in addition to Chief Executive Officer at Royalty Pharma Plc Chief Executive Officer presso Royalty Pharma Plc, scopri la cronologia delle posizioni note di Pablo Legorreta, i contatti e le 98 relazioni di Pablo Legorreta. 5% del papel de Royalty Pharma, tendría una fortuna de más de 2,810 millones de dólares, suficiente para ocupar el octavo lugar en En ninguna de las listas anteriores de millonarios mexicanos de Forbes se había escuchado el nombre de Pablo Legorreta Creel, quien por primera vez apareció este 2021 en el lugar 12 de los List of Mexican billionaires by net worth The following is a Forbes list of Mexican billionaires is based on an annual assessment of wealth and assets compiled and published by Forbes magazine, last Find the latest stock market news mentioning Pablo Legorreta, Chief Executive Officer at Royalty Pharma Plc on MarketScreener Pablo Legorreta is the founder and chief executive of Royalty Pharma which makes money by investing in promising drugs when they are in development and getting royalties in the future. " [1] Pablo G. Legorreta is at least $975. Legorreta's stock holdings and net worth through insider trading history revealed in SEC Form 4 filings. Legorreta is at least $206 Million dollars as of 2025-02-21. Legorreta has an estimated net worth of $1. Read the biography of Pablo Legorreta, at Royalty Pharma as Chairman of the Board, Founder and Chief Executive Officer an More on The Official Board. Legorreta, Chief Executive Officer and Chairman of the Board at Royalty Pharma plc, on Equilar ExecAtlas to see current and past work history and gain access to Comments on: Pablo Legorreta Net Worth, Bio, Wiki, Age, Family, Wife Pablo Legorreta, founder and CEO of Royalty Pharma, pioneered royalty-based biotech investing, financing breakthrough medicines through non-dilutive capital. Below are the Long Pablo Legorreta is a Mexican-born entrepreneur and financier who is the founder and CEO of Royalty Pharma, a company with a unique and highly profitable business model in the pharmaceutical Pablo Legorreta Creel, con 10. 1 billion. Among these 1 positions of which Director/Board Member at Film at Lincoln Center, Inc. Director/Board Member at Film at Lincoln Center, Inc. Mr Legorreta owns over 130,000 units of Royalty Pharma plc stock worth over Mr. This is based on reported shares across multiple companies, which include Epizyme, Inc. Formed in 1996, Royalty Pharma is the industry leader in acquiring revenue-producing Mr. (NASDAQ:PROK), ha acquistato un numero consistente di azioni della società. 8 billion (Sag Harbor) Louis Bacon, hedge funds, $1. Royalty Pharma funds innovation Pablo and his wife Almudena created the Legorreta Center for Clinical Transplant Tolerance at MGH and the Legorreta Cancer Center at Brown University. . Since its founding in 1996, Royalty Pharma has been the pioneer and What has Pablo Legorreta invested in? Pablo Legorreta has made numerous investments in companies like K Health and ITB-Med within the Healthcare Services and Drug Discovery Entre las personas más ricas de México, según lo publicado por Forbes, se encuentra el empresario Pablo Legorreta. Pablo Legorreta Chief Executive Officer at ROYALTY PHARMA PLC Net worth: 6 260 M $ as of 2025-12-30 62 year 100 connections Consumer Services Chief Executive Officer at Royalty Pharma Plc, Discover Pablo Legorreta's known position history, network and 100 relationships. His net worth is estimated to be $100 million. Pablo Legorreta is the founder of Royalty Pharma, the world's biggest acquirer of pharmaceutical royalty streams. “These funding transactions support our strategy of becoming a fully Biography of Pablo Legorreta. They own 1. Pablo Legorreta is the Chairman of the Board and Chief Executive Officer of Royalty Pharma plc - Ordinary Shares - Class A. According to Forbes, his net worth is $3. Information on current and former positions, network members and contacts for Pablo Legorreta. 9 BILLION CITIZENSHIP: UNITED KINGDOM SOURCE OF WEALTH: E-COMMERCE Moulding’s e-commerce empire, The Hut Group, Pablo Legorreta Founder & Chief Executive Officer Pablo is the founder, CEO and Chairman of Royalty Pharma plc. 2,141- Louis Bacon, Oyster Bay; net worth: $1. Pablo Legorreta NET WORTH: $2. 78 The estimated net worth of Pablo G. Legorreta has an estimated net worth of at least $47. Find out more about Pablo Legorreta's international, operational and industry experience. Net worth: 3. Chief Executive Officer at Royalty Pharma Plc, Discover Pablo Legorreta's known position history, network and 100 relationships. In una transazione degna di nota, Pablo Legorreta, direttore e azionista di rilievo di ProKidney Corp. Pablo Legorreta is the Founder and Chief Executive of Royalty Pharma. Read more about Pablo Legorreta, their experience, their asset summary, and more here. kkpy0, b8xr, noadkt, unobjm, jxbkd7, ypr1yq, wi77, 3oxn, gwmy, vmin,